Glaucoma UK announces £100,000 Health and Social Care Professionals Award for 2024
Glaucoma UK is pleased to announce that applications for its Health and Social Care Professionals Research Award are now open.
Children with ‘lazy eye’ are at increased risk of serious disease in adulthood
Adults who had amblyopia (‘lazy eye’) in childhood are more likely to experience hypertension, obesity, and metabolic syndrome in adulthood, as well as an increased risk of heart attack, finds a new study led by UCL researchers.
Presbyopia edition of BCLA research project due to be published
A “pioneering” BCLA global consensus report will deliver evidence-based guidance to eyecare professionals on all aspects of presbyopia and its management – shaping the future of patient care for years to come.
Blindness from some inherited eye diseases may be caused by gut bacteria
Sight loss in certain inherited eye diseases may be caused by gut bacteria, and is potentially treatable by antimicrobials, finds a new study in mice co-led by a UCL and Moorfields researcher.
Glaucoma UK and The Royal College of Ophthalmologists announce research award 2024
Glaucoma UK and The Royal College of Ophthalmologists are collaborating to run this prestigious award which has previously funded a range of research topics from prospective stem cell treatments to the use of big data in patient risk stratification.
£5 million award for world-leading research facilities within new eye health centre
12 February 2024
|
research, infrastructure, Sir Jules Thorn, education, trust, moorfields, UCL, NHS, Oriel
The Sir Jules Thorn Charitable Trust has awarded £5 million to UCL in partnership with Moorfields Eye Charity and Moorfields Eye Hospital to support Oriel – a centre for advancing eye health, opening in 2027.
Study calls for thorough investigation of patients with early signs of retinal vascular disease
Patients with the eye condition Paracentral Acute Middle Maculopathy (PAMM) would benefit from further investigation, as their risk of heart attacks and strokes may be greater than previously shown, suggests a new study led by researchers at Moorfields Eye Hospital NHS Foundation Trust.
The Worshipful Company of Spectacle Makers awards 2023 Ruskell Medal for research
8 January 2024
|
gene therapy, Cristina Martinez-Fernandez de la Camara, awards, competition, research, paper, retinal dystrophy
The Worshipful Company of Spectacle Makers has awarded its prestigious bronze Ruskell Medal for 2023 to Dr Cristina Martinez-Fernandez de la Camara, a senior scientist in the Clinical Ophthalmology Research Group at the Nuffield Department of Clinical Neurosciences at the University of Oxford, for her work on RPGR-associated retinal dystrophy.
World-class Health Innovation Hub to be built in Govan
21 November 2023
|
University of Glasgow, Govan, infrastructure, research, academia, Kadans Science Partner
The University of Glasgow and Kadans Science Partner, supported by Scottish Enterprise, are delighted to announce the construction of a new Health Innovation Hub in Govan, setting the stage for a thriving life sciences cluster in the area.
Researchers pursue personalised pathways for glaucoma care
25 September 2023
|
glaucoma, Health Care Quality, research, innovation, Giovanni Montesano, RCOphth, glaucoma uk
Researchers, funded by Glaucoma UK in partnership with The Royal College of Ophthalmologists, are investigating the potential for personalised glaucoma care by mapping clinical trial data and real-word outcomes to individuals.
Landmark review of glaucoma treatment and research published by Moorfields-led team
Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.
WATCH: Novel imaging technology reveals role of immune cells in early diabetic cataract development
In this video interview, Proffessor Ali Hafezi-Moghadam and Professor Dr. Christoph Rußmann discuss their findings on the role of immune cells in early diabetic cataract development.
